Nov 06, 2018
Company to Participate in USA Corporate Executive Office Program
Nov 01, 2017
Mesa Biotech, Inc., a privately-held, molecular diagnostic company that has developed an affordable PCR testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced that it will present original research at.
Aug 08, 2017
Mesa Biotech, Inc., a privately-held, molecular diagnostic company that has developed a testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced that it will present at the ninth annual Next Generation..